Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452906 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study of Omeprazole and PA21
A Phase 1 study, sponsored by Vifor Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT01452906: Completed Phase 1 study, sponsored by Vifor Pharma.
NCT01452906 is a Phase 1 study that has completed, run by Vifor Pharma. The registered enrollment target is 45 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01452906, a Phase 1 study, has completed, sponsored by Vifor Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Omeprazole is affected by PA21.
Primary Outcome
Area under the plasma concentration versus time curve from time zero (pre-dose) to 24 hours
Interventions
- DRUG PA21 and Omeprazole with food
- DRUG No PA21; Omeprazole with food
- DRUG PA21 with food, Omeprazole 2hrs later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
What the finished NCT01452906 record still lists
NCT01452906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 3 interventions - of which PA21 and Omeprazole with food is the first listed.
NCT01452906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01452906 about?
NCT01452906 is a clinical study titled "A Drug-Drug Interaction Study of Omeprazole and PA21". The purpose of this study is to determine if Omeprazole is affected by PA21.
What is the current status of trial NCT01452906?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2011-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01452906?
The interventions under investigation include: PA21 and Omeprazole with food (DRUG), No PA21; Omeprazole with food (DRUG), PA21 with food, Omeprazole 2hrs later (DRUG).
Who is sponsoring clinical trial NCT01452906?
This trial is sponsored by Vifor Pharma, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01452906's enrollment target sits among peer trials
45 1066th of 2000 higher than 915 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia